Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Neoplasm Metastasis
Clinical trial register · Italy

Neoplasm Metastasis Trials in Italy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6779 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:19 UTC
6779
Studies in scope
all four open statuses
4070
Recruiting now
open to new participants
1013
Lead sponsors
across recruiting studies
Top sites
Milan 8 Naples 6 Rome 5 Bologna 5 Meldola 4
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company9 Genentech, Inc.1 Boehringer Ingelheim1 Istituto Ortopedico Rizzoli1
Site location
Milan8 Naples6 Rome5 Bologna5 Meldola4 Bari3 Padova3 Roma3 Catania2 Florence2 Misterbianco2 Parma2 Udine2 Pisa1 Bergamo1 Genova1 Monza1 Lecce1 Lucca1 Modena1 Prato1 Potenza1 Catanzaro1 Aviano (PN)1 Aviano1 Genoa1 Castelfranco Veneto1 Terni1 Trento1 Candiolo (TO)1 Grosseto1 Viterbo1
All 32 locations
Target enrolment
to

Neoplasm Metastasis trials in Italy

12 of 6779 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Eli Lilly and Company
Phase 3
800
Bergamo, Bologna, Florence, Genova, Meldola, Milan, Misterbianco, Monza
2025-12-22
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bari, Milan, Naples, Padova, Pisa, Roma, Rome
2025-12-12
Recruiting
Eli Lilly and Company
Phase 3
1,630
Bologna, Catania, Lecce, Lucca, Milan, Modena, Naples, Prato
2025-10-22
Recruiting
Eli Lilly and Company
Phase 3
1,264
Bari, Bologna, Catania, Milan, Naples, Padova, Roma, Rome
2023-12-21
Recruiting
Eli Lilly and Company
Phase 1
677
Milan, Roma
2023-01-12
Active, closed
Eli Lilly and Company
Phase 2
46
Rome, Bologna
2022-09-20
Active, closed
Eli Lilly and Company
Phase 3
925
Meldola, Rome, Milan, Castelfranco Veneto, Terni, Trento
2022-04-14
Active, closed
Eli Lilly and Company
Phase 3
368
Misterbianco, Meldola, Udine, Bari, Grosseto, Milan, Viterbo
2022-03-11
Active, closed
Eli Lilly and Company
Phase 3
874
Naples, Aviano, Rome, Genoa, Florence, Padova
2021-10-04
Recruiting
Boehringer Ingelheim
Phase 1
554
Candiolo (TO), Naples, Parma
2021-07-02
Recruiting
Istituto Ortopedico Rizzoli
Observational
120
Bologna
2018-01-01
Active, closed
Genentech, Inc.
Phase 2
378
Potenza, Catanzaro, Naples, Meldola, Parma, Aviano (PN), Udine, Milan
2008-10-16
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-italy/condition/neoplasm-metastasis

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,779 studies in total at the last sync on 10 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition Neoplasm Metastasis.

How many Neoplasm Metastasis trials are recruiting in Italy?

7 of the 12 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Neoplasm Metastasis), 12 studies
PhaseStudiesRecruitingShare
Phase 37458.3%
Phase 12216.7%
Phase 22016.7%
Observational118.3%

Most active sponsors

Lead sponsors with the most studies (Neoplasm Metastasis)
Lead sponsorStudiesRecruiting
Eli Lilly and Company95
Boehringer Ingelheim11
Genentech, Inc.10
Istituto Ortopedico Rizzoli11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.